Open the mobile version, with barcode scanning
Class II Terminated

CONTRAVE (naltrexone HCl and bupropion HCl )extended-release tablets, 8 mg/ 90 mg, 120-count bottle, Rx only, Manufactured for Orexigen Therapeutics, Inc., La Jolia, CA 92037, Distributed by Takeda Ph…

Why: Failed Tablet/Capsule Specifications: Potential tablet defect of broken tablets and/or equatorial splitting of the bilayer tablets into the two drug components.

Company
Takeda Pharmaceuticals North America, Inc.
Deerfield, IL, United States
Reported
Jul 8, 2015
Recall started
May 21, 2015
Ended
Feb 20, 2018
Where sold
Nationwide
Amount
3,619 bottles
Full product description
CONTRAVE (naltrexone HCl and bupropion HCl )extended-release tablets, 8 mg/ 90 mg, 120-count bottle, Rx only, Manufactured for Orexigen Therapeutics, Inc., La Jolia, CA 92037, Distributed by Takeda Pharmaceuticals America, Inc., Deerfield, IL 60015, NDC 64764-890-99.
Lots / codes affected
Lot # B21642; Exp. 03/17

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.